These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38006807)

  • 1. Mosloflavone from Fissistigma petelotii ameliorates oncogenic multidrug resistance by STAT3 signaling modulation and P-glycoprotein blockade.
    Chien PY; Lan YH; Wu IT; Huang YP; Hung CC
    Phytomedicine; 2024 Jan; 123():155210. PubMed ID: 38006807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel flavonoid from Fissistigma cupreonitens, 5‑hydroxy‑7,8‑dimethoxyflavanone, competitively inhibited the efflux function of human P-glycoprotein and reversed cancer multi-drug resistance.
    Teng YN; Lin KI; Lin YC; Thang TD; Lan YH; Hung CC
    Phytomedicine; 2021 May; 85():153528. PubMed ID: 33735724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caffeic Acid Attenuates Multi-Drug Resistance in Cancer Cells by Inhibiting Efflux Function of Human P-glycoprotein.
    Teng YN; Wang CCN; Liao WC; Lan YH; Hung CC
    Molecules; 2020 Jan; 25(2):. PubMed ID: 31936160
    [No Abstract]   [Full Text] [Related]  

  • 4. β-carotene reverses multidrug resistant cancer cells by selectively modulating human P-glycoprotein function.
    Teng YN; Sheu MJ; Hsieh YW; Wang RY; Chiang YC; Hung CC
    Phytomedicine; 2016 Mar; 23(3):316-23. PubMed ID: 26969385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cinnamophilin overcomes cancer multi-drug resistance via allosterically modulating human P-glycoprotein on both drug binding sites and ATPase binding sites.
    Teng YN; Huang BH; Huang SY; Wu IT; Wu TS; Lee TE; Hung CC
    Biomed Pharmacother; 2021 Dec; 144():112379. PubMed ID: 34794239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of multidrug resistance by Fissistigma latifolium-derived chalconoid 2-hydroxy-4,5,6-trimethoxydihydrochalcone in cancer cell lines overexpressing human P-glycoprotein.
    Teng YN; Hung CC; Kao PH; Chang YT; Lan YH
    Biomed Pharmacother; 2022 Dec; 156():113832. PubMed ID: 36242847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal effect of FW-04-806, a macrolide dilactone compound, on multidrug resistance mediated by ABCB1 and ABCG2 in vitro and in vivo.
    Zhang Z; Ma C; Li P; Wu M; Ye S; Fu L; Xu J
    Cell Commun Signal; 2019 Sep; 17(1):110. PubMed ID: 31472682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morin reverses P-glycoprotein-mediated multidrug-resistance in KBChR-8-5 cancer cell lines.
    Zhao Y; Xu S; Hao W; Fu Y
    Cell Biochem Funct; 2024 Jul; 42(5):e4083. PubMed ID: 38938150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zhankuic Acids A, B and C from
    Teng YN; Wang YH; Wu TS; Hung HY; Hung CC
    Biomolecules; 2019 Nov; 9(12):. PubMed ID: 31766413
    [No Abstract]   [Full Text] [Related]  

  • 10. Glabridin resensitizes p-glycoprotein-overexpressing multidrug-resistant cancer cells to conventional chemotherapeutic agents.
    Qian J; Xia M; Liu W; Li L; Yang J; Mei Y; Meng Q; Xie Y
    Eur J Pharmacol; 2019 Jun; 852():231-243. PubMed ID: 30959046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Marine sponge-derived sipholane triterpenoids reverse P-glycoprotein (ABCB1)-mediated multidrug resistance in cancer cells.
    Abraham I; Jain S; Wu CP; Khanfar MA; Kuang Y; Dai CL; Shi Z; Chen X; Fu L; Ambudkar SV; El Sayed K; Chen ZS
    Biochem Pharmacol; 2010 Nov; 80(10):1497-506. PubMed ID: 20696137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel application of rhein and its prodrug diacerein for reversing cancer-related multidrug resistance through the dual inhibition of P-glycoprotein efflux and STAT3-mediated P-glycoprotein expression.
    Teng YN; Kao MC; Huang SY; Wu TS; Lee TE; Kuo CY; Hung CC
    Biomed Pharmacother; 2022 Jun; 150():112995. PubMed ID: 35658243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bipiperidinyl derivatives of 23-hydroxybetulinic acid reverse resistance of HepG2/ADM and MCF-7/ADR cells.
    Zhang DM; Li YJ; Shu C; Ruan ZX; Chen WM; Yiu A; Peng YH; Wang J; Lan P; Yao Z; Fung KP; Fu LW; Chen ZS; Ye WC
    Anticancer Drugs; 2013 Jun; 24(5):441-54. PubMed ID: 23466650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tenulin and isotenulin inhibit P-glycoprotein function and overcome multidrug resistance in cancer cells.
    Chang YT; Wang CCN; Wang JY; Lee TE; Cheng YY; Morris-Natschke SL; Lee KH; Hung CC
    Phytomedicine; 2019 Feb; 53():252-262. PubMed ID: 30668405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitization of ABCB1 overexpressing cells to chemotherapeutic agents by FG020326 via binding to ABCB1 and inhibiting its function.
    Dai CL; Liang YJ; Chen LM; Zhang X; Deng WJ; Su XD; Shi Z; Wu CP; Ashby CR; Akiyama S; Ambudkar SV; Chen ZS; Fu LW
    Biochem Pharmacol; 2009 Aug; 78(4):355-64. PubMed ID: 19410561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crizotinib (PF-02341066) reverses multidrug resistance in cancer cells by inhibiting the function of P-glycoprotein.
    Zhou WJ; Zhang X; Cheng C; Wang F; Wang XK; Liang YJ; To KK; Zhou W; Huang HB; Fu LW
    Br J Pharmacol; 2012 Jul; 166(5):1669-83. PubMed ID: 22233293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel (-)-arctigenin derivatives inhibit signal transducer and activator of transcription 3 phosphorylation and P-glycoprotein function resensitizing multidrug resistant cancer cells in vitro and in vivo.
    Yu KH; Kuo CY; Wu IT; Chi CH; Tsai KC; Kuo PC; Zeng JW; Hung CC; Hung HY
    Eur J Pharmacol; 2023 Dec; 960():176146. PubMed ID: 37884184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of ABCB1 Transporter Confers Resistance to mTOR Inhibitor WYE-354 in Cancer Cells.
    Wang J; Yang DH; Yang Y; Wang JQ; Cai CY; Lei ZN; Teng QX; Wu ZX; Zhao L; Chen ZS
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32092870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BBA, a derivative of 23-hydroxybetulinic acid, potently reverses ABCB1-mediated drug resistance in vitro and in vivo.
    Zhang DM; Shu C; Chen JJ; Sodani K; Wang J; Bhatnagar J; Lan P; Ruan ZX; Xiao ZJ; Ambudkar SV; Chen WM; Chen ZS; Ye WC
    Mol Pharm; 2012 Nov; 9(11):3147-59. PubMed ID: 23046348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BI-2865, a pan-KRAS inhibitor, reverses the P-glycoprotein induced multidrug resistance in vitro and in vivo.
    Yang Q; To KKW; Hu G; Fu K; Yang C; Zhu S; Pan C; Wang F; Luo K; Fu L
    Cell Commun Signal; 2024 Jun; 22(1):325. PubMed ID: 38872211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.